Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014.
Bassirou DiarraD GoitaS TounkaraM SanogoB BayaA C G TogoM MaigaY S SarroA KoneB KoneO M'BayeN CoulibalyH KassambaraA CisseM BelsonM A PolisJ OtuF GehreM AntonioS DaoS SiddiquiR L MurphyB C de JongS DialloPublished in: BMC infectious diseases (2016)
The drug resistance levels, including MDR, found in this study are relatively high, likely related to the selected referral population. While worrisome, the numbers remained stable over the study period. These findings prompt a nationwide drug resistance survey, as well as continuous surveillance of all retreatment patients, which will provide more accurate results on countrywide drug resistance rates and ensure that MDR patients access appropriate second line treatment.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- public health
- emergency department
- mycobacterium tuberculosis
- multidrug resistant
- high resolution
- patient reported outcomes
- combination therapy
- hepatitis c virus
- hiv aids
- mass spectrometry
- patient reported
- human immunodeficiency virus
- electronic health record
- replacement therapy